Dna demethylating therapy reverts mesenchymal stromal cells derived from high risk myelodysplastic patients to a normal phenotype

Giulia Maurizi; Domenico Mattiucci; Marianna Mariani; Marco Ciarlantini; Sabrina Traini; Stefania Mancini; Attilio Olivieri; Pietro Leoni; Antonella Poloni

doi:10.1111/bjh.14115

DOI: 10.1111/bjh.14115

,

PMID: 27102230

Issn Print: 0007-1048

Publication Date: 2017/06/01

Print

DNA demethylating therapy reverts mesenchymal stromal cells derived from high risk myelodysplastic patients to a normal phenotype

Giulia Maurizi; Domenico Mattiucci; Marianna Mariani; Marco Ciarlantini; Sabrina Traini; Stefania Mancini; Attilio Olivieri; Pietro Leoni; Antonella Poloni

+ Author Information

Author Information: Clinica di Ematologia


		Checking for direct PDF access through Ovid

View on Journal Site

Abstract

Abstract unavailable for this article.


		Loading Related Articles